Predictive biomarkers help to optimize therapy decisions, as they provide information on the likelihood of response to a given chemotherapeutic.
The predictive biomarkers market is expected to register a fast growth over the forecast period owing to the increase in the prevalence rate of cancer.
Market Analysis and Insights: Global Predictive Biomarkers Market
The global Predictive Biomarkers market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Predictive Biomarkers Scope and Market Size
Predictive Biomarkers market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Predictive Biomarkers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The following players are covered in this report:
Siemens Healthcare
Roche Diagnostic
G.E. Healthcare
Abbott Laboratories
Qiagen
Johnson and Johnson
...
Predictive Biomarkers Breakdown Data by Type
Cancer
Neurological Disorder
Cardiovascular Disorder
Immunological Disorder
Others
Predictive Biomarkers Breakdown Data by Application
Diagnostic Centers
Academic Research Institutes
CRO’S
Bio-Pharmaceutical Companies
The predictive biomarkers market is expected to register a fast growth over the forecast period owing to the increase in the prevalence rate of cancer.
Market Analysis and Insights: Global Predictive Biomarkers Market
The global Predictive Biomarkers market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Predictive Biomarkers Scope and Market Size
Predictive Biomarkers market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Predictive Biomarkers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The following players are covered in this report:
Siemens Healthcare
Roche Diagnostic
G.E. Healthcare
Abbott Laboratories
Qiagen
Johnson and Johnson
...
Predictive Biomarkers Breakdown Data by Type
Cancer
Neurological Disorder
Cardiovascular Disorder
Immunological Disorder
Others
Predictive Biomarkers Breakdown Data by Application
Diagnostic Centers
Academic Research Institutes
CRO’S
Bio-Pharmaceutical Companies
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Predictive Biomarkers Revenue
1.4 Market by Type
1.4.1 Global Predictive Biomarkers Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Cancer
1.4.3 Neurological Disorder
1.4.4 Cardiovascular Disorder
1.4.5 Immunological Disorder
1.4.6 Others
1.5 Market by Application
1.5.1 Global Predictive Biomarkers Market Share by Application: 2020 VS 2026
1.5.2 Diagnostic Centers
1.5.3 Academic Research Institutes
1.5.4 CRO’S
1.5.5 Bio-Pharmaceutical Companies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Predictive Biomarkers Market Perspective (2015-2026)
2.2 Global Predictive Biomarkers Growth Trends by Regions
2.2.1 Predictive Biomarkers Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Predictive Biomarkers Historic Market Share by Regions (2015-2020)
2.2.3 Predictive Biomarkers Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Predictive Biomarkers Market Growth Strategy
2.3.6 Primary Interviews with Key Predictive Biomarkers Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Predictive Biomarkers Players by Market Size
3.1.1 Global Top Predictive Biomarkers Players by Revenue (2015-2020)
3.1.2 Global Predictive Biomarkers Revenue Market Share by Players (2015-2020)
3.1.3 Global Predictive Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Predictive Biomarkers Market Concentration Ratio
3.2.1 Global Predictive Biomarkers Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Predictive Biomarkers Revenue in 2019
3.3 Predictive Biomarkers Key Players Head office and Area Served
3.4 Key Players Predictive Biomarkers Product Solution and Service
3.5 Date of Enter into Predictive Biomarkers Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Predictive Biomarkers Historic Market Size by Type (2015-2020)
4.2 Global Predictive Biomarkers Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Predictive Biomarkers Market Size by Application (2015-2020)
5.2 Global Predictive Biomarkers Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Predictive Biomarkers Market Size (2015-2020)
6.2 Predictive Biomarkers Key Players in North America (2019-2020)
6.3 North America Predictive Biomarkers Market Size by Type (2015-2020)
6.4 North America Predictive Biomarkers Market Size by Application (2015-2020)
7 Europe
7.1 Europe Predictive Biomarkers Market Size (2015-2020)
7.2 Predictive Biomarkers Key Players in Europe (2019-2020)
7.3 Europe Predictive Biomarkers Market Size by Type (2015-2020)
7.4 Europe Predictive Biomarkers Market Size by Application (2015-2020)
8 China
8.1 China Predictive Biomarkers Market Size (2015-2020)
8.2 Predictive Biomarkers Key Players in China (2019-2020)
8.3 China Predictive Biomarkers Market Size by Type (2015-2020)
8.4 China Predictive Biomarkers Market Size by Application (2015-2020)
9 Japan
9.1 Japan Predictive Biomarkers Market Size (2015-2020)
9.2 Predictive Biomarkers Key Players in Japan (2019-2020)
9.3 Japan Predictive Biomarkers Market Size by Type (2015-2020)
9.4 Japan Predictive Biomarkers Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Predictive Biomarkers Market Size (2015-2020)
10.2 Predictive Biomarkers Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Predictive Biomarkers Market Size by Type (2015-2020)
10.4 Southeast Asia Predictive Biomarkers Market Size by Application (2015-2020)
11 India
11.1 India Predictive Biomarkers Market Size (2015-2020)
11.2 Predictive Biomarkers Key Players in India (2019-2020)
11.3 India Predictive Biomarkers Market Size by Type (2015-2020)
11.4 India Predictive Biomarkers Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Predictive Biomarkers Market Size (2015-2020)
12.2 Predictive Biomarkers Key Players in Central & South America (2019-2020)
12.3 Central & South America Predictive Biomarkers Market Size by Type (2015-2020)
12.4 Central & South America Predictive Biomarkers Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Siemens Healthcare
13.1.1 Siemens Healthcare Company Details
13.1.2 Siemens Healthcare Business Overview
13.1.3 Siemens Healthcare Predictive Biomarkers Introduction
13.1.4 Siemens Healthcare Revenue in Predictive Biomarkers Business (2015-2020))
13.1.5 Siemens Healthcare Recent Development
13.2 Roche Diagnostic
13.2.1 Roche Diagnostic Company Details
13.2.2 Roche Diagnostic Business Overview
13.2.3 Roche Diagnostic Predictive Biomarkers Introduction
13.2.4 Roche Diagnostic Revenue in Predictive Biomarkers Business (2015-2020)
13.2.5 Roche Diagnostic Recent Development
13.3 G.E. Healthcare
13.3.1 G.E. Healthcare Company Details
13.3.2 G.E. Healthcare Business Overview
13.3.3 G.E. Healthcare Predictive Biomarkers Introduction
13.3.4 G.E. Healthcare Revenue in Predictive Biomarkers Business (2015-2020)
13.3.5 G.E. Healthcare Recent Development
13.4 Abbott Laboratories
13.4.1 Abbott Laboratories Company Details
13.4.2 Abbott Laboratories Business Overview
13.4.3 Abbott Laboratories Predictive Biomarkers Introduction
13.4.4 Abbott Laboratories Revenue in Predictive Biomarkers Business (2015-2020)
13.4.5 Abbott Laboratories Recent Development
13.5 Qiagen
13.5.1 Qiagen Company Details
13.5.2 Qiagen Business Overview
13.5.3 Qiagen Predictive Biomarkers Introduction
13.5.4 Qiagen Revenue in Predictive Biomarkers Business (2015-2020)
13.5.5 Qiagen Recent Development
13.6 Johnson and Johnson
13.6.1 Johnson and Johnson Company Details
13.6.2 Johnson and Johnson Business Overview
13.6.3 Johnson and Johnson Predictive Biomarkers Introduction
13.6.4 Johnson and Johnson Revenue in Predictive Biomarkers Business (2015-2020)
13.6.5 Johnson and Johnson Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Predictive Biomarkers Revenue
1.4 Market by Type
1.4.1 Global Predictive Biomarkers Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Cancer
1.4.3 Neurological Disorder
1.4.4 Cardiovascular Disorder
1.4.5 Immunological Disorder
1.4.6 Others
1.5 Market by Application
1.5.1 Global Predictive Biomarkers Market Share by Application: 2020 VS 2026
1.5.2 Diagnostic Centers
1.5.3 Academic Research Institutes
1.5.4 CRO’S
1.5.5 Bio-Pharmaceutical Companies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Predictive Biomarkers Market Perspective (2015-2026)
2.2 Global Predictive Biomarkers Growth Trends by Regions
2.2.1 Predictive Biomarkers Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Predictive Biomarkers Historic Market Share by Regions (2015-2020)
2.2.3 Predictive Biomarkers Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Predictive Biomarkers Market Growth Strategy
2.3.6 Primary Interviews with Key Predictive Biomarkers Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Predictive Biomarkers Players by Market Size
3.1.1 Global Top Predictive Biomarkers Players by Revenue (2015-2020)
3.1.2 Global Predictive Biomarkers Revenue Market Share by Players (2015-2020)
3.1.3 Global Predictive Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Predictive Biomarkers Market Concentration Ratio
3.2.1 Global Predictive Biomarkers Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Predictive Biomarkers Revenue in 2019
3.3 Predictive Biomarkers Key Players Head office and Area Served
3.4 Key Players Predictive Biomarkers Product Solution and Service
3.5 Date of Enter into Predictive Biomarkers Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Predictive Biomarkers Historic Market Size by Type (2015-2020)
4.2 Global Predictive Biomarkers Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Predictive Biomarkers Market Size by Application (2015-2020)
5.2 Global Predictive Biomarkers Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Predictive Biomarkers Market Size (2015-2020)
6.2 Predictive Biomarkers Key Players in North America (2019-2020)
6.3 North America Predictive Biomarkers Market Size by Type (2015-2020)
6.4 North America Predictive Biomarkers Market Size by Application (2015-2020)
7 Europe
7.1 Europe Predictive Biomarkers Market Size (2015-2020)
7.2 Predictive Biomarkers Key Players in Europe (2019-2020)
7.3 Europe Predictive Biomarkers Market Size by Type (2015-2020)
7.4 Europe Predictive Biomarkers Market Size by Application (2015-2020)
8 China
8.1 China Predictive Biomarkers Market Size (2015-2020)
8.2 Predictive Biomarkers Key Players in China (2019-2020)
8.3 China Predictive Biomarkers Market Size by Type (2015-2020)
8.4 China Predictive Biomarkers Market Size by Application (2015-2020)
9 Japan
9.1 Japan Predictive Biomarkers Market Size (2015-2020)
9.2 Predictive Biomarkers Key Players in Japan (2019-2020)
9.3 Japan Predictive Biomarkers Market Size by Type (2015-2020)
9.4 Japan Predictive Biomarkers Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Predictive Biomarkers Market Size (2015-2020)
10.2 Predictive Biomarkers Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Predictive Biomarkers Market Size by Type (2015-2020)
10.4 Southeast Asia Predictive Biomarkers Market Size by Application (2015-2020)
11 India
11.1 India Predictive Biomarkers Market Size (2015-2020)
11.2 Predictive Biomarkers Key Players in India (2019-2020)
11.3 India Predictive Biomarkers Market Size by Type (2015-2020)
11.4 India Predictive Biomarkers Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Predictive Biomarkers Market Size (2015-2020)
12.2 Predictive Biomarkers Key Players in Central & South America (2019-2020)
12.3 Central & South America Predictive Biomarkers Market Size by Type (2015-2020)
12.4 Central & South America Predictive Biomarkers Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Siemens Healthcare
13.1.1 Siemens Healthcare Company Details
13.1.2 Siemens Healthcare Business Overview
13.1.3 Siemens Healthcare Predictive Biomarkers Introduction
13.1.4 Siemens Healthcare Revenue in Predictive Biomarkers Business (2015-2020))
13.1.5 Siemens Healthcare Recent Development
13.2 Roche Diagnostic
13.2.1 Roche Diagnostic Company Details
13.2.2 Roche Diagnostic Business Overview
13.2.3 Roche Diagnostic Predictive Biomarkers Introduction
13.2.4 Roche Diagnostic Revenue in Predictive Biomarkers Business (2015-2020)
13.2.5 Roche Diagnostic Recent Development
13.3 G.E. Healthcare
13.3.1 G.E. Healthcare Company Details
13.3.2 G.E. Healthcare Business Overview
13.3.3 G.E. Healthcare Predictive Biomarkers Introduction
13.3.4 G.E. Healthcare Revenue in Predictive Biomarkers Business (2015-2020)
13.3.5 G.E. Healthcare Recent Development
13.4 Abbott Laboratories
13.4.1 Abbott Laboratories Company Details
13.4.2 Abbott Laboratories Business Overview
13.4.3 Abbott Laboratories Predictive Biomarkers Introduction
13.4.4 Abbott Laboratories Revenue in Predictive Biomarkers Business (2015-2020)
13.4.5 Abbott Laboratories Recent Development
13.5 Qiagen
13.5.1 Qiagen Company Details
13.5.2 Qiagen Business Overview
13.5.3 Qiagen Predictive Biomarkers Introduction
13.5.4 Qiagen Revenue in Predictive Biomarkers Business (2015-2020)
13.5.5 Qiagen Recent Development
13.6 Johnson and Johnson
13.6.1 Johnson and Johnson Company Details
13.6.2 Johnson and Johnson Business Overview
13.6.3 Johnson and Johnson Predictive Biomarkers Introduction
13.6.4 Johnson and Johnson Revenue in Predictive Biomarkers Business (2015-2020)
13.6.5 Johnson and Johnson Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
